Tyra Biosciences, Inc. Share-based Payment Arrangement, Expense, Tax Benefit
Tyra Biosciences, Inc. (TYRA) reported Share-based Payment Arrangement, Expense, Tax Benefit of $100.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2024-11-07
- Tyra Biosciences, Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2024-09-30 was $100.00K, a 0.00% change year-over-year.
- Tyra Biosciences, Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2024-06-30 was $100.00K, a 50.00% decline year-over-year.
- Tyra Biosciences, Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2024-03-31 was $100.00K, a 0.00% change year-over-year.
- Tyra Biosciences, Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2023-09-30 was $100.00K, a 0.00% change year-over-year.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month |
|---|---|---|---|
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-07 | $200.00K derived: sum of 2 quarters · filed 2024-11-07 | $200.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-07 | $200.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-09 | ||
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-07 | $300.00K derived: sum of 2 quarters · filed 2024-11-07 | $400.00K 10-Q · filed 2024-11-07 |
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-07 | $300.00K 10-Q · filed 2024-08-07 | |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-09 | ||
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-07 | $200.00K derived: sum of 2 quarters · filed 2023-11-07 | $400.00K 10-Q · filed 2023-11-07 |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-10 | $300.00K 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $200.00K 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |